Global Ischemic Stroke Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1329

Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
In 2018, the global Ischemic Stroke Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Ischemic Stroke Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ischemic Stroke Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
Merck
Boehringer Ingelheim
Sanofi
Johnson & Johnson
Bayer
Biogen
Abbott Laboratories
Genentech
Daiichi Sankyo

Market segment by Type, the product can be split into
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Others

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ischemic Stroke Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Ischemic Stroke Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ischemic Stroke Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ischemic Stroke Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Tissue Plasminogen Activator
1.4.3 Anticoagulant
1.4.4 Antiplatelet
1.4.5 Antihypertensive
1.4.6 Others
1.5 Market by Application
1.5.1 Global Ischemic Stroke Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Ischemic Stroke Therapeutics Market Size
2.2 Ischemic Stroke Therapeutics Growth Trends by Regions
2.2.1 Ischemic Stroke Therapeutics Market Size by Regions (2014-2025)
2.2.2 Ischemic Stroke Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Ischemic Stroke Therapeutics Market Size by Manufacturers
3.1.1 Global Ischemic Stroke Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Ischemic Stroke Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Ischemic Stroke Therapeutics Key Players Head office and Area Served
3.3 Key Players Ischemic Stroke Therapeutics Product/Solution/Service
3.4 Date of Enter into Ischemic Stroke Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Ischemic Stroke Therapeutics Market Size by Type (2014-2019)
4.2 Global Ischemic Stroke Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Ischemic Stroke Therapeutics Market Size (2014-2019)
5.2 Ischemic Stroke Therapeutics Key Players in United States
5.3 United States Ischemic Stroke Therapeutics Market Size by Type
5.4 United States Ischemic Stroke Therapeutics Market Size by Application

6 Europe
6.1 Europe Ischemic Stroke Therapeutics Market Size (2014-2019)
6.2 Ischemic Stroke Therapeutics Key Players in Europe
6.3 Europe Ischemic Stroke Therapeutics Market Size by Type
6.4 Europe Ischemic Stroke Therapeutics Market Size by Application

7 China
7.1 China Ischemic Stroke Therapeutics Market Size (2014-2019)
7.2 Ischemic Stroke Therapeutics Key Players in China
7.3 China Ischemic Stroke Therapeutics Market Size by Type
7.4 China Ischemic Stroke Therapeutics Market Size by Application

8 Japan
8.1 Japan Ischemic Stroke Therapeutics Market Size (2014-2019)
8.2 Ischemic Stroke Therapeutics Key Players in Japan
8.3 Japan Ischemic Stroke Therapeutics Market Size by Type
8.4 Japan Ischemic Stroke Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Ischemic Stroke Therapeutics Market Size (2014-2019)
9.2 Ischemic Stroke Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Ischemic Stroke Therapeutics Market Size by Type
9.4 Southeast Asia Ischemic Stroke Therapeutics Market Size by Application

10 India
10.1 India Ischemic Stroke Therapeutics Market Size (2014-2019)
10.2 Ischemic Stroke Therapeutics Key Players in India
10.3 India Ischemic Stroke Therapeutics Market Size by Type
10.4 India Ischemic Stroke Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Ischemic Stroke Therapeutics Market Size (2014-2019)
11.2 Ischemic Stroke Therapeutics Key Players in Central & South America
11.3 Central & South America Ischemic Stroke Therapeutics Market Size by Type
11.4 Central & South America Ischemic Stroke Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ischemic Stroke Therapeutics Introduction
12.1.4 Pfizer Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ischemic Stroke Therapeutics Introduction
12.2.4 Merck Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ischemic Stroke Therapeutics Introduction
12.3.4 Boehringer Ingelheim Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ischemic Stroke Therapeutics Introduction
12.4.4 Sanofi Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ischemic Stroke Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ischemic Stroke Therapeutics Introduction
12.6.4 Bayer Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Biogen
12.7.1 Biogen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ischemic Stroke Therapeutics Introduction
12.7.4 Biogen Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.7.5 Biogen Recent Development
12.8 Abbott Laboratories
12.8.1 Abbott Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ischemic Stroke Therapeutics Introduction
12.8.4 Abbott Laboratories Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.8.5 Abbott Laboratories Recent Development
12.9 Genentech
12.9.1 Genentech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ischemic Stroke Therapeutics Introduction
12.9.4 Genentech Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.9.5 Genentech Recent Development
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Company Details
12.10.2 Company Description and Business Overview
12.10.3 Ischemic Stroke Therapeutics Introduction
12.10.4 Daiichi Sankyo Revenue in Ischemic Stroke Therapeutics Business (2014-2019)
12.10.5 Daiichi Sankyo Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details